NICORANDIL IN PATIENTS WITH HEART FAILURE IN CHD

DOI: https://doi.org/10.29296/25877305-2019-01-06
Download full text PDF
Issue: 
1
Year: 
2019

M. Makarovskaya(1); Professor A. Ryazanov(2), MD; A. Kudryavtsev(2); K. Kapitonov(1), Candidate of Medical Sciences 1-Clinical Diagnostic Center Four, Moscow Healthcare Department; 2-I.M. Sechenov First Moscow State Medical University (Sechenov University)

The paper presents the results of the study covering 175 patients with coronary heart disease concurrent with heart failure, who were additionally given nicorandil. The incidence of angina attacks and the changes in the functional class of heart failure and in the quality of life were studied.
Keywords: 
cardiology
ischemic heart failure
nicorandil
antianginal efficacy

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Bolezni serdca po Braunval`du. T. 3 / M.: Logosfera, 2013 [Bolezni serdtsa po Braunval'du. T. 3. / M.: Logosfera, 2013. (in Russ.)]
  2. Vertkin F.L., Knorring G.Yu. Za ramkami invazivnoy kardiologii // Consilium Medicum. – 2016; 18 (10): 43–8 [Vertkin A.L., Knorring G.Yu. Beyond the scope of invasive cardiology // Consilium Medicum. – 2016; 18 (10): 43–8 (in Russ.)].
  3. IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomized trial // Lancet. – 2002; 359 (9314): 1269–75.
  4. Eshihisa A., Sato Yu., Vatanabe S. i dr. Snizhenie smertnosti u bol`nyh s serdechnoy nedostatochnost`yu ishemicheskoy e`tiologii, prinimayushhih nikorandil // Consilium Medicum. – 2017; 19 (10): 74–8 [Yoshihisa A., Sato Y., Watanabe S. et al. Decreased cardiac mortality with nicorandil in patients with ischemic heart failure // Consillium Medicum. – 2017; 19 (10): 74–8 (in Russ.)]. DOI: 10.26442/2075-1753_19.10.74-78
  5. Task Force, Montalescot G., Sechtem U. et al. 2013 ESC guidelineson the management of stable coronary artery disease of the European Society of Cardiology // Eur. Heart J. – 2013; 34 (38): 2949–3003.
  6. Zhu W. et al. Double-blind, multicenter, active controlled, randomized clinical trial to assess the safety and efficacy of orally administered nicorandil in patients with stable angina pectoris in China // Circ. J. – 2007; 71 (6): 826–33.
  7. Japanese Coronary Artery Disease (JCAD) Study Investigators. Current status of the background of patients with coronary artery disease in Japan // Circ. J. – 2006; 70 (10): 1269–75.
  8. Voronina V.P., Marcevich S.Yu., Kutishenko N.P. i dr. Ocenka antiishemicheskogo i antianginal`nogo e`ffektov nikorandila s pomoshh`yu nagruzochnyh testov na tredmile v ramkah issledovaniya KVAZAR // Ros. kardiol. zhurn. – 2017; 2 (149): 97–103 [Voronina V.P., Martsevich S.Iu., Kutishenko N.P. et al. Voronina V.P., Martsevich S. Yu., Kutishenko N.P. et al. ASSESSMENT OF Antiischemic and antianginal effects of nicorandil by treadmill test, under the framework of KVAZAR study // Ros. kardiol. zhurn. – 2017; 2 (149): 97–103 (in Russ.)].
  9. Ryabihin E.A., Mozheyko M.E., Krasil`nikov Yu.A. i dr. Dopolnitel`nye vozmozhnosti v lechenii ishemicheskoy bolezni serdca, oslozhnennoy hronicheskoy serdechnoy nedostatochnost`yu s nizkoy frakciey vybrosa levogo zheludochka // Serdechnaya nedostatochnost`. – 2016; 17 (1): 3–9 [Ryabihin E.A., Mozhejko M.E., Krasil'nikov Yu.A. et al. Dopolnitel'nye vozmozhnosti v lechenii ishemicheskoj bolezni serdca, oslozhnennoj hronicheskoj serdechnoj nedostatochnost'yu s nizkoj frakciej vybrosa levogo zheludochka // Serdechnaya nedostatochnost'. – 2016; 17 (1): 3–9 (in Russ.)]
  10. Marcevich S.Yu., Lukina Yu.V., Kutishenko N.P. i dr. Nablyudatel`noe mnogocentrovoe issledovanie primeneniya nikorandila u bol`nyh stabil`noy ishemicheskoy bolezn`yu serdca s vysokim serdechno-sosudistym riskom (NIKEYa): dizayn, pervye rezul`taty // Ros. kardiol. zhurn. – 2017; 9 (149): 75–82. [Martsevich S. Yu., Lukina Yu. V., Kutishenko N.P. et al. Observational multicenter trial of nicorandil use in stable coronary heart disease high risk patients (NIKEA): design and first results // Ros. kardiol. zhurn. – 2017; 9 (149): 75–82 (in Russ.)]
  11. VNOK. Racional`naya farmakoterapiya bol`nyh SSZ. Rossiyskie rekomendacii // Kardiovask. ter. i profilakt. – 2009; 8 (6; Pril. 4): 12 [VNOK. Ratsional'naia farmakoterapiia bol'nykh SSZ. Rossiiskie rekomendatsii // Kardiovaskuliarnaia terapiia i profilaktika. – 2009; 8 (6; Pril. 4): 12 (in Russ.)]